Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Perrigo behind the label: positive sales, modernization efforts pace 26% stock rise.

This article was originally published in The Tan Sheet

Executive Summary

PERRIGO STOCK UP 26%, PACED BY POSITIVE SALES, SYSTEMS MODERNIZATION efforts in the third quarter. The largest U.S. private labeler of OTCs and H&BAs saw its stock price rise 3-1/4 points in the three-month period to 15-3/4. Perrigo helped stabilize the consumer products segment of "The Tan Sheet" Quarterly Index, which was flat due predominantly to a decline by its most heavily weighted component, Procter & Gamble (off 2.2% to 69-1/16)

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS087616

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel